Contact us today for a complimentary consultation with a qualified attorney near you.
-August 6, 2008
Drug manufacturers Actavis Totowa recently recalled generic medications that were produced at their Little Falls, New Jersey plant.
The recall was issued after an FDA inspection of the plant revealed problems in the manufacturing process of Actavis’ products.
FDA Finds Glitches in Manufacturing Process
According to the FDA, the Actavis Totowa plant, located in New Jersey, failed to meet standards for good manufacturing practices.
As a result, the drug makers issued a voluntary national recall of their generic medications from all pharmacies, hospitals and retailers.
Problems with Digitek in the Past
This is not the first time that Actavis has been questioned in terms of their manufacturing process and the overall safety of their drugs.
In April, the company was forced to recall their heart medication, Digitek, after researchers discovered the tablets contained twice the amount of its active ingredient.
The strength of the Digitek tablets caused severe risks to patients taking the drug and it was found that some of these faulty tablets were manufactured at the New Jersey plant that is now under a watchful eye.
Since Digitek’s recall, patients have reported suffering from serious illnesses and injuries while taking the medication.
FDA Warns Actavis Totowa
In 2006, the FDA reportedly issued a warning to Actavis about the condition of their Little Falls plant and now officials are debating whether to take further action.
(Source: UPI.com)
Have you been harmed by taking Digitek or another drug that has been recalled? Please contact us to speak with a trustworthy attorney who will allow you to receive the legal guidance and support you deserve for any wrongdoing.